First-in-Class Histone Acetyltransferase (HAT) Activator, YF2, Modulates Immune Evasion in DLBCL, Enhancing the Effects of Immune Checkpoint Blockade

Estrella, B., Pazos, M. A., Ricker, E. C., Ryu, Y. K., Piorczynski, T. B., Liu, Y., Tolu, S., & Amengual, J. E. (2022). First-in-Class Histone Acetyltransferase (HAT) Activator, YF2, Modulates Immune Evasion in DLBCL, Enhancing the Effects of Immune Checkpoint Blockade. Blood, 140(Supplement 1), 358–359. https://doi.org/10.1182/blood-2022-166929
Authors:
Brian Estrella
Manuel A. Pazos
Edd Ricker
Yun Kyoung Ryu
Ted B. Piorczynski
Yuxuan Liu
Seda S. Tolu
Jennifer E. Amengual
Affiliated Authors:
Brian Estrella
Manuel A. Pazos
Edd Ricker
Yun Kyoung Ryu
Ted B. Piorczynski
Seda S. Tolu
Jennifer E. Amengual
Publication Type:
Article
Unique ID:
10.1182/blood-2022-166929
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: